GC
Grimes & Company Portfolio holdings
AUM
$3.67B
1-Year Return
12.49%
This Quarter Return
+4.66%
1 Year Return
+12.49%
3 Year Return
+42.9%
5 Year Return
+87.85%
10 Year Return
+203.44%
AUM
$1.25B
AUM Growth
+$118M
(+10%)
Cap. Flow
+$65.8M
Cap. Flow
% of AUM
5.27%
Top 10 Holdings %
Top 10 Hldgs %
39.58%
Holding
256
New
14
Increased
93
Reduced
81
Closed
7
Top Buys
| 1 |
SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
|
$56.9M |
| 2 |
iShares Short Treasury Bond ETF
SHV
|
$36M |
| 3 |
RTN
Raytheon Company
RTN
|
$10.8M |
| 4 |
Cognizant
CTSH
|
$7.32M |
| 5 |
KLA
KLAC
|
$4.05M |
Top Sells
| 1 |
SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
|
$28.4M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
$11.7M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
$10.5M |
| 4 |
Tractor Supply
TSCO
|
$8.58M |
| 5 |
Infosys
INFY
|
$7.43M |
Sector Composition
| 1 | Technology | 11.94% |
| 2 | Healthcare | 7.28% |
| 3 | Industrials | 6.78% |
| 4 | Financials | 4.15% |
| 5 | Consumer Discretionary | 4.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Visa
V
$681B
| $544K | 0.04% |
3,621
-74
| -2% | -$11.1K |
|
152
Allete
ALE
$3.7B
| $541K | 0.04% |
7,212
| – | – |
|
153
BP
BP
$88.4B
| $541K | 0.04% |
12,288
-1,012
| -8% | -$44.6K |
|
154
Philip Morris
PM
$251B
| $540K | 0.04% |
6,630
-576
| -8% | -$46.9K |
|
155
Lincoln National
LNC
$8.19B
| $533K | 0.04% |
7,878
| – | – |
|
156
iShares Russell 1000 Growth ETF
IWF
$118B
| $512K | 0.04% |
3,284
-1,198
| -27% | -$187K |
|
157
Starbucks
SBUX
$98.9B
| $506K | 0.04% |
8,901
+153
| +2% | +$8.7K |
|
158
TJX Companies
TJX
$157B
| $491K | 0.04% |
8,766
+740
| +9% | +$41.4K |
|
159
Valero Energy
VLO
$48.3B
| $491K | 0.04% |
4,313
+554
| +15% | +$63.1K |
|
160
Bristol-Myers Squibb
BMY
$95B
| $483K | 0.04% |
7,786
-397
| -5% | -$24.6K |
|
161
Eversource Energy
ES
$23.5B
| $476K | 0.04% |
7,754
-5
| -0.1% | -$307 |
|
162
iShares National Muni Bond ETF
MUB
$38.7B
| $467K | 0.04% |
4,323
| – | – |
|
163
Eli Lilly
LLY
$666B
| $466K | 0.04% |
4,347
+50
| +1% | +$5.36K |
|
164
Meta Platforms (Facebook)
META
$1.88T
| $460K | 0.04% |
2,798
-618
| -18% | -$102K |
|
165
Marsh & McLennan
MMC
$101B
| $460K | 0.04% |
5,563
| – | – |
|
166
SPDR S&P Biotech ETF
XBI
$5.28B
| $448K | 0.04% |
+4,670
| New | +$448K |
|
167
Teradyne
TER
$19B
| $445K | 0.04% |
+12,038
| New | +$445K |
|
168
Southern Company
SO
$101B
| $440K | 0.04% |
10,098
+400
| +4% | +$17.4K |
|
169
iShares Russell 2000 ETF
IWM
$67.4B
| $436K | 0.03% |
2,585
-954
| -27% | -$161K |
|
170
ProShares UltraShort Euro
EUO
$34M
| $434K | 0.03% |
18,625
-8,325
| -31% | -$194K |
|
171
Invesco QQQ Trust
QQQ
$368B
| $425K | 0.03% |
2,288
| – | – |
|
172
Vanguard Small-Cap Value ETF
VBR
$31.6B
| $425K | 0.03% |
3,052
| – | – |
|
173
Altria Group
MO
$112B
| $413K | 0.03% |
6,839
-59
| -0.9% | -$3.56K |
|
174
Target
TGT
$42.1B
| $402K | 0.03% |
4,555
-41
| -0.9% | -$3.62K |
|
175
Invesco Large Cap Value ETF
PWV
$1.19B
| $401K | 0.03% |
10,721
| – | – |
|